Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.140
-0.020 (-1.72%)
At close: Nov 13, 2026, 4:00 PM EST
1.160
+0.020 (1.75%)
After-hours: Nov 13, 2026, 7:30 PM EST
Cellectar Biosciences Stock Forecast
CLRB's stock price has decreased by -67.43% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cellectar Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $11.5. The average 1-year stock price forecast is 908.77% higher than the current stock price, while the lowest is $10 (+777.19%) and the highest is $15 (+1,215.79%).
Price Target: $11.5 (+908.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cellectar Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $10 | Buy | Maintains | $10 | +777.19% | Nov 11, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Reiterates $10 | Buy | Reiterates | $10 | +777.19% | Aug 14, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Initiates $15 | Buy | Initiates | $15 | +1,215.79% | Jul 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.21
from -8.35
EPS Next Year
-1.99
from -2.21
EPS and Forward PE are based on non-GAAP adjusted numbers.